vs

Side-by-side financial comparison of LIVEPERSON INC (LPSN) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $59.3M, roughly 1.4× LIVEPERSON INC). PROCEPT BioRobotics Corp runs the higher net margin — -38.1% vs -77.8%, a 39.7% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -19.0%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -16.6%).

LivePerson is a global technology company that develops conversational commerce and AI software.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

LPSN vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.4× larger
PRCT
$83.1M
$59.3M
LPSN
Growing faster (revenue YoY)
PRCT
PRCT
+39.2% gap
PRCT
20.2%
-19.0%
LPSN
Higher net margin
PRCT
PRCT
39.7% more per $
PRCT
-38.1%
-77.8%
LPSN
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-16.6%
LPSN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
LPSN
LPSN
PRCT
PRCT
Revenue
$59.3M
$83.1M
Net Profit
$-46.1M
$-31.6M
Gross Margin
73.2%
64.9%
Operating Margin
-68.7%
-4.1%
Net Margin
-77.8%
-38.1%
Revenue YoY
-19.0%
20.2%
Net Profit YoY
58.9%
-27.9%
EPS (diluted)
$-9.22
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LPSN
LPSN
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$59.3M
$76.4M
Q3 25
$60.2M
$83.3M
Q2 25
$59.6M
$79.2M
Q1 25
$64.7M
$69.2M
Q4 24
$73.2M
$68.2M
Q3 24
$74.2M
$58.4M
Q2 24
$79.9M
$53.4M
Net Profit
LPSN
LPSN
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-46.1M
$-29.8M
Q3 25
$8.7M
$-21.4M
Q2 25
$-15.7M
$-19.6M
Q1 25
$-14.1M
$-24.7M
Q4 24
$-112.1M
$-18.9M
Q3 24
$-28.3M
$-21.0M
Q2 24
$41.8M
$-25.6M
Gross Margin
LPSN
LPSN
PRCT
PRCT
Q1 26
64.9%
Q4 25
73.2%
60.6%
Q3 25
71.4%
64.8%
Q2 25
69.7%
65.4%
Q1 25
71.8%
63.9%
Q4 24
77.4%
64.0%
Q3 24
73.1%
63.2%
Q2 24
79.4%
59.0%
Operating Margin
LPSN
LPSN
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-68.7%
-40.6%
Q3 25
-24.2%
-27.8%
Q2 25
-10.8%
-28.0%
Q1 25
-26.2%
-39.7%
Q4 24
-138.0%
-28.9%
Q3 24
-21.6%
-38.4%
Q2 24
-37.3%
-50.3%
Net Margin
LPSN
LPSN
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-77.8%
-39.1%
Q3 25
14.5%
-25.7%
Q2 25
-26.4%
-24.7%
Q1 25
-21.8%
-35.8%
Q4 24
-153.2%
-27.6%
Q3 24
-38.1%
-35.9%
Q2 24
52.3%
-48.0%
EPS (diluted)
LPSN
LPSN
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-9.22
$-0.54
Q3 25
$-2.76
$-0.38
Q2 25
$-0.17
$-0.35
Q1 25
$-0.24
$-0.45
Q4 24
$-17.23
$-0.34
Q3 24
$-4.74
$-0.40
Q2 24
$-0.33
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LPSN
LPSN
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$95.0M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$-44.5M
$347.7M
Total Assets
$454.7M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LPSN
LPSN
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$95.0M
$286.5M
Q3 25
$106.7M
$294.3M
Q2 25
$162.0M
$302.7M
Q1 25
$176.3M
$316.2M
Q4 24
$183.2M
$333.7M
Q3 24
$142.1M
$196.8M
Q2 24
$146.0M
$214.1M
Total Debt
LPSN
LPSN
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
LPSN
LPSN
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$-44.5M
$365.9M
Q3 25
$-22.1M
$380.3M
Q2 25
$-82.4M
$385.8M
Q1 25
$-74.9M
$389.2M
Q4 24
$-67.3M
$402.2M
Q3 24
$45.9M
$241.2M
Q2 24
$66.6M
$251.8M
Total Assets
LPSN
LPSN
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$454.7M
$508.1M
Q3 25
$511.4M
$511.5M
Q2 25
$604.2M
$513.1M
Q1 25
$596.2M
$519.4M
Q4 24
$607.8M
$534.0M
Q3 24
$692.0M
$374.1M
Q2 24
$703.8M
$374.4M
Debt / Equity
LPSN
LPSN
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LPSN
LPSN
PRCT
PRCT
Operating Cash FlowLast quarter
$-9.7M
Free Cash FlowOCF − Capex
$-12.0M
FCF MarginFCF / Revenue
-20.2%
Capex IntensityCapex / Revenue
3.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-42.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LPSN
LPSN
PRCT
PRCT
Q1 26
Q4 25
$-9.7M
$-10.3M
Q3 25
$-6.0M
$-6.6M
Q2 25
$-11.7M
$-15.0M
Q1 25
$-3.1M
$-17.0M
Q4 24
$-3.1M
$-32.4M
Q3 24
$4.8M
$-18.8M
Q2 24
$-17.9M
$-15.7M
Free Cash Flow
LPSN
LPSN
PRCT
PRCT
Q1 26
Q4 25
$-12.0M
$-12.2M
Q3 25
$-8.9M
$-9.5M
Q2 25
$-14.8M
$-17.8M
Q1 25
$-6.9M
$-18.8M
Q4 24
$-6.8M
$-33.6M
Q3 24
$-230.0K
$-19.0M
Q2 24
$-22.9M
$-16.8M
FCF Margin
LPSN
LPSN
PRCT
PRCT
Q1 26
Q4 25
-20.2%
-15.9%
Q3 25
-14.8%
-11.4%
Q2 25
-24.9%
-22.5%
Q1 25
-10.6%
-27.2%
Q4 24
-9.2%
-49.2%
Q3 24
-0.3%
-32.6%
Q2 24
-28.7%
-31.4%
Capex Intensity
LPSN
LPSN
PRCT
PRCT
Q1 26
Q4 25
3.9%
2.4%
Q3 25
4.8%
3.4%
Q2 25
5.3%
3.5%
Q1 25
5.8%
2.7%
Q4 24
5.0%
1.7%
Q3 24
6.8%
0.4%
Q2 24
6.2%
2.0%
Cash Conversion
LPSN
LPSN
PRCT
PRCT
Q1 26
Q4 25
Q3 25
-0.69×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-0.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LPSN
LPSN

Hosted Services Business$51.0M86%
Professional Services$8.3M14%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons